Work-related musculoskeletal disorder (WMSD) is a common occupational injury. Among the occupational injuries of agricultural workers, 93% are related to WMSD, with the shoulder being the second most affected area. This paper presents a passive upper-limb exoskeleton (PULE) with a gas spring and four-bar mechanism developed to aid the daily activities associated with orchard farming. The PULE is used to assist the arm-lifting process, reducing the physical exertion of farmers and the risk of developing WMSD. Electromyography (EMG) measurements of 26 participants were obtained to evaluate the difference in physical exertion with and without the PULE. Two arm activities: fruit thinning, with the arms raised and maintained at 100°, and pesticide spraying, with the hands swinging from 0° to 100° and back, were simulated. Using the PULE decreased muscle tension of the anterior deltoid (AD) by 17.64–19.86%. The PULE also decreased the AD activity by 37.67–39.57% during the actual orchard farming operations. The Qualisys motion capture system indicated that the difference in the lifting angle of the upper limb with and without the PULE was less than 1° and not significant (α > 0.05). Thus, the PULE did not affect the flexibility of the wearer in orchard farming activities.

Ideal artificial tissue scaffolds should provide an in vitro microenvironment comparable to native human skin tissue to direct cell functions, regulate tissue homeostasis, and promote tissue regeneration. A sandwich-like composite scaffold consisting of a hydrogel layer and two aligned nanofibre layers was fabricated and applied as a wound-healing dressing. Gentamicin was preloaded into the hydrogel middle layer and naturally released for antibacterial activity during the healing period. Nanofibrous layers embedded on the top and bottom surfaces of the hydrogel improved the tensile strength fivefold (1560 ​kPa and 465% strain) while serving as a diffusion barrier to reduce the gentamicin initial burst release (30%–15%). Inspired by the extracellular matrix (ECM), the surface of nanofibre top layer was patterned with triangular microarrays using micro-moulding approach to reflect the multidimensional structure of ECM. Biocompatibility of the scaffold is proven from cytotoxicity and haemolysis studies. Fibroblast cells revealed a highly elongated and consistent alignment modulated by the micropatterned fibrous layer and directed their migration towards the wound area. Excisional wounds treated with the scaffold promoted 97.49% wound closure with low inflammation and rapid re-epithelialization and angiogenesis. This scaffold, with its tailored functionality capable of accelerating wound healing, has high potential in tissue engineering applications.

Drug delivery systems (DDS) are commonly employed to administer drug-loaded composites to their therapeutic targets both in vitro and in vivo. Thus, we herein report the study of imiquimod-poly(ε-caprolactone) (IMQ-PCL) nanofibrous meshes for application in melanoma therapy. The preparation route employed was based on the electrospinning technique, with the melanoma cells being cultured on electrospun nanofibrous meshes to study their biocompatibility. All parameters employed, including the flow rate and polymer solution concentration, were examined to gain an improved understanding of the factors influencing the diameter and morphology of the electrospun fibre. The optimised parameters were employed to produce 12 IMQ-PCL nanofibrous meshes with diameters ranging from 100 to 900 nm to the melanoma cell viability. The relationship between the fibrous diameter and the imiquimod release profile was also determined using UV-Vis spectroscopy. In addition, similar results were obtained for the simulated imiquimod release profile obtained by COMSOL Multiphysics^®. The IMQ-PCL nanofibrous meshes were found to decrease cell viability by ≥50%, with the number of cells dropping by ~10% over 48 h. As the cell viability was affected by the release of imiquimod, we believe that IMQ-PCL nanofibrous meshes are a promising drug delivery system for application in melanoma therapy.

Surface wettability plays an important role in determining the function of a wound dressing. Dressings with hydrophobic surfaces are suitable for bacterial adsorption, however, a hydrophilic surface is needed to improve cell attachment for most anchorage-dependent cell types. Furthermore, the hydrophobicity/hydrophilicity of the surface can be used to direct cellular processes such as cell initial attachment, adhesion, and migration during wound healing. Thus, a surface with an ability to switch their surface wettability improves the practicality of the dressing. In this study, we propose a temporary surface wettability tuning for surface patterning utilizing plasma treatment. Polycaprolactone (PCL) and polydimethylsiloxane (PDMS) surfaces were treated with tetrafluoromethane (CF₄), sulphur hexafluoride (SF₆), and oxygen (O₂) plasma, and the effects on the surface wettability, roughness, and chemical composition were investigated. Based on the contact angle measurement, CF₄ plasma altered surface wettability of PCL and PDMS films to hydrophobic and hydrophilic, respectively. After CF₄ treatment, better attachment of primary mouse embryonic fibroblast cell (3T3) was observed on the treated PDMS surface. Embedding PCL into PDMS generated a hydrophobic-hydrophilic pattern mixture surface, which offers great potential in the tissue engineering field such as cell patterning and guidance.

Centrifugal electrospinning (CES) was developed by integrating the electrospinning (ES) and centrifugal spinning (CS) concepts to produce oriented and diameter-controlled fibrous scaffolds which were then applied to stimulate the behaviour of fibroblast cells. During the fabrication process, polymer concentrations, rotational speeds, operating voltages, and needle sizes were key parameters to affect the diameters of produced fibres. The mathematical model indicated that the centrifugal force with the power of 2 was the main influence in fabricating thinner fibres, followed by electrostatic force with the power of 1. The developed CES technique could fabricate fibres scaffold ranging from 210 ± 50 nm to 2814 ± 96 nm by only applying low operating voltages and rotation speed which were 10 kV and up to 2000 rpm, respectively. Through optimum parameter, random and aligned nanofibrous were fabricated with the diameter being distributed mainly at 200–400 nm. Aligned nanofibrous demonstrated a high degree of orientation when 88% of the nanofibrous varied at 0°–10°. Compared to random structure, aligned nanofibrous presented high tensile strength, which was approximately 4.35 MPa and appropriate flexibility with 73% of elongation break. Aligned nanofibrous exhibited high cell viabilities with a 2.34 absorbance rate at day 14. The fibroblast cells elongated and accelerated in the orientation of the aligned nanofibrous. Results suggest that fibre aligned scaffolds are possible candidates for wound dressing application.